deutetrabenazine vs dopamine
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of deutetrabenazine and dopamine. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
7.4 Neuroleptic Drugs The risk of parkinsonism, NMS, and akathisia may be increased by concomitant use of AUSTEDO XR or AUSTEDO with dopamine antagonists or antipsychotics.
Austedo
Intropin
Austedo and Austedo XR help control movements in adults with Huntington's disease or tardive dyskinesia. It works by changing the levels of certain chemicals in the brain.
Dopamine injection helps improve blood flow in patients suffering from shock. It is used when shock is caused by problems with blood distribution or reduced heart function.
Austedo and Austedo XR are used to treat chorea (uncontrollable movements) caused by Huntington's disease. They also treat tardive dyskinesia, which causes repetitive, involuntary movements. These medicines can help you control these movements.
Dopamine injection is used to improve blood flow in people with shock. Shock can happen when your body isn't getting enough blood flow. This medicine helps to increase blood pressure and improve heart function during these emergencies.
Austedo and Austedo XR affect a protein in the brain called VMAT2. This protein helps move certain chemicals like dopamine. By blocking VMAT2, Austedo and Austedo XR help regulate these chemicals, which reduces unwanted movements.
Dopamine works by stimulating certain receptors in your body. This stimulation helps to increase your heart rate and blood pressure. It also improves blood flow to your kidneys.
- • Feeling sleepy
- • Diarrhea
- • Dry mouth
- • Feeling tired
- • Runny nose
No common side effects listed.
- Depression 463
- Dyskinesia 403
- Death 402
- Tremor 330
- Somnolence 305
- Hypotension 336
- Acute Kidney Injury 182
- Cardiac Arrest 165
- Renal Failure 162
- Condition Aggravated 125
Austedo and Austedo XR can increase the risk of depression and suicidal thoughts in people with Huntington's disease. If you have Huntington's disease, your doctor will monitor you closely for any changes in your mood or behavior. Tell your doctor right away if you feel depressed or have thoughts of harming yourself. You should not take Austedo or Austedo XR if you are suicidal or have untreated depression.
Dopamine can cause tissue damage if it leaks out of the vein. Tell your doctor right away if you notice any pain, swelling, or redness around the IV site. This medicine may also cause heart rhythm problems. If you have asthma, be aware this drug contains sodium metabisulfite, which can cause a severe allergic reaction.
It is not known if Austedo or Austedo XR will harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if Austedo or Austedo XR passes into breast milk. Talk to your doctor about the best way to feed your baby if you are taking this medicine.
There is not enough information about the safety of dopamine during pregnancy. Tell your doctor if you are pregnant or plan to become pregnant. It is not known if dopamine passes into breast milk. Talk to your doctor if you are breastfeeding.
Also Compare, Nearby Drugs
Compare deutetrabenazine with
How to Read This deutetrabenazine vs dopamine Comparison
deutetrabenazine is classified in the VMAT2 Inhibitor drug class, while dopamine sits within the Inotropic / Vasopressor class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, deutetrabenazine has 1,903 submissions while dopamine has 970. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to this drug lowers the amount of dopamine available in the brain. taking it with other drugs that affect dopamine can increase the risk of serious movement-related side effects like stiffness or restlessness.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for deutetrabenazine or dopamine.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.